IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial

Nutrition Journal

Volumn 9, Issue 1, 2010, Pages

  Boelsma, Esther ^a   Kloek, Joris ^b  

^a TNO   (Netherlands)

^b DSM BIOTECHNOLOGY CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CALCIUM; CARBOHYDRATE; CELLULOSE; FAT; ISOLEUCINE PROLINE PROLINE; LEUCINE PROLINE PROLINE; METHIONINE ALANINE PROLINE; MILK PROTEIN; PLACEBO; POTASSIUM; PROTEIN; PROTEIN HYDROLYSATE; RENIN; SODIUM; UNCLASSIFIED DRUG; ISOLEUCYL PROLYL PROLINE; ISOLEUCYL-PROLYL-PROLINE; OLIGOPEPTIDE;

ADULT; ARTICLE; ASH; BLOOD PRESSURE MEASUREMENT; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FIBER; HEMATOLOGY; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; AGED; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; MIDDLE AGED; MILK; PHASE 1 CLINICAL TRIAL; PREHYPERTENSION;

AGED; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-OVER STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MILK; MILK PROTEINS; OLIGOPEPTIDES; PREHYPERTENSION; PROTEIN HYDROLYSATES;

EID: 78049479104     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-9-52     Document Type: Article

References (45)

1. Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. MC Houston, Expert Rev Cardiovasc Ther 2007 5 681 691 10.1586/14779072.5.4.681 17605647
2. Overview of dietary influences on atherosclerotic vascular disease: epidemiology and prevention. GN Thomas BM Cheung SY Ho DJ Macfarlane HB Deng SM McGhee J Woo TH Lam B Tomlinson, Cardiovasc Hematol Disord Drug Targets 2007 7 87 97 17584043
3. Functional foods for the prevention and treatment of cardiovascular diseases: cholesterol and beyond. I Rudkowska PJ Jones, Expert Rev Cardiovasc Ther 2007 5 477 490 10.1586/14779072.5.3.477 17489672
4. Lactotripeptides and antihypertensive effects: a critical review. E Boelsma J Kloek, Br J Nutr 2009 101 6 776 786 10.1017/S0007114508137722 19061526
5. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. JY Xu LQ Qin PY Wang W Li C Chang, Nutrition 2008 24 10 933 940 10.1016/j.nut.2008.04.004 18562172
6. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. AH Pripp, Food Nutr Res 2008 52 1 9
7. The effect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension - a pilot study on humans. L Seppo O Kerojoki T Suomalainen R Korpela, Milchwissenschaft 2002 57 124 127
8. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. L Seppo T Jauhiainen T Poussa R Korpela, Am J Clin Nutr 2003 77 326 330 12540390
9. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Tuomilehto J Lindström J Hyyrynen R Korpela ML Karhunen L Mikkola T Jauhiainen L Seppo A Nissinen, J Hum Hypertens 2004 18 795 802 10.1038/sj.jhh.1001745 15175633
10. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. T Jauhiainen H Vapaatalo T Poussa S Kyronpalo M Rasmussen R Korpela, Am J Hypertens 2005 18 1600 1605 10.1016/j.amjhyper.2005.06.006 16364832
11. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. MF Engberink EG Schouten FJ Kok LA van Mierlo IA Brouwer JM Geleijnse, Hypertension 2008 51 399 405 10.1161/HYPERTENSIONAHA.107.098988 18086944
12. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. K van der Zander ML Bots AA Bak MM Koning PW de Leeuw, Am J Clin Nutr 2008 88 1697 1702 10.3945/ajcn.2008.26003 19064533
13. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. K van der Zander M Jäkel V Bianco MM Koning, J Hum Hypertens 2008 22 804 806 10.1038/jhh.2008.59 18528405
14. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. PW de Leeuw K van der Zander AA Kroon RM Rennenberg MM Koning, Blood Press 2009 18 1-2 44 50 10.1080/08037050902761209 19247842
15. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. LA van Mierlo MM Koning K van der Zander R Draijer, Am J Clin Nutr 2009 89 617 623 10.3945/ajcn.2008.26918 19106238
16. The use of amealpeptide in the treatment of patients with stage I and stage II hypertension - data from the AHEAD study. JM Neutel M Nonaka S Hendler MA Weber, J Hypertens 2006 24 suppl 4 84
17. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Sano K Ohki T Higuchi K Aihara S Mizuno O Kajimoto S Nakagawa Y Kajimoto Y Nakamura, J Med Food 2005 8 423 30 10.1089/jmf.2005.8.423 16379551
18. Dietary calcium and blood pressure: a meta-analysis of randomized controlled trials. PS Allender JA Cutler D Follmann FP Cappuccio J Pryer P Elliott, Ann Intern Med 1996 124 825 831 8610952
19. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated meta-analysis of randomized controlled trials. LE Griffith GH Guyatt RJ Cook HC Bucher DJ Cook, Am J Hypertens 1999 12 84 92 10.1016/S0895-7061(98)00224-6 10075392
20. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. SH Jee ER Miller III E Guallar VK Singh LJ Appel MJ Klag, Am J Hypertens 2002 15 691 696 10.1016/S0895-7061(02) 02964-3 12160191
21. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. LA van Mierlo LR Arends MT Streppel MP Zeegers FJ Kok DE Grobbee JM Geleijnse, J Hum Hypertens 2006 20 571 580 10.1038/sj.jhh.1002038 16673011
22. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. PK Whelton J He JA Cutler FL Brancati LJ Appel D Follmann MJ Klag, JAMA 1997 277 1624 1632 10.1001/jama.277.20.1624 9168293
23. Dietary phosphorus and blood pressure: international study of macro- and micro-nutrients and blood pressure. P Elliott H Kesteloot LJ Appel AR Dyer H Ueshima Q Chan IJ Brown L Zhao J Stamler INTERMAP Cooperative Research Group, Hypertension 2008 51 669 675 10.1161/HYPERTENSIONAHA.107.103747 18250363
24. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil,, et al. JAMA 2003 289 2560 2572 10.1001/jama.289.19.2560 12748199
25. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. M Foltz EE Meynen V Bianco C van Platerink TM Koning J Kloek, J Nutr 2007 137 953 958 17374660
26. The column - August 2009. http://digital.findanalytichem.com/nxtbooks/ advanstaruk/thecolumn0809/#/2/OnePage
27. Hypotensive Effects of Sour Milk in Subjects with Mild or Moderate Hypertension. O Kajimoto Y Nakamura H Yada S Moriguchi H Hirata T Takahashi, J Jpn Soc Nutr Food Sci 2001 54 347 354
28. Hypotensive effects of the tablets containing lactotripeptides (VPP, IPP). O Kajimoto K Aihara H Hirata R Takahashi Y Nakamura, J Nutr Food 2001 4 51 61
29. Antihypertensive effects of liquid yogurts containing lactotripeptides (VPP, IPP) in mild hypertensive subjects. O Kajimoto T Kurosaki J Mizutani N Ikeda K Kaneko K Aihara M Yabune Y Nakamura, J Nutr Food 2002 5 55 66
30. Clinical effects of new sour milk drink on mild or moderate hypertensive subjects. H Hirata Y Nakamura H Yada S Moriguchi O Kajimoto T Takahashi, J New Rem & Clin 2002 51 61 69
31. Safety evaluation of excessive intake of the tablet containing lactotripeptides (VPP, IPP) on healthy volunteers. O Kajimoto K Aihara H Hirata R Takahashi Y Nakamura, J Nutr Food 2001 4 37 46
32. The effect of sour milk on blood pressure in untreated hypertensive and normotensive subjects. H Itakura S Ikemoto S Terada K Kondo, J Jap Soc Clin Nutr 2001 23 26 31
33. Effect of large high intake of tablets containing lactotripeptides (VPP, IPP) on blood pressure, pulse rate and clinical parameters in healthy volunteers. K Yasuda K Aihara K Komazaki M Mochii Y Nakamura, J Nutr Food 2001 4 63 72
34. Safety evaluation of excessive intake of drink containing lactotripeptides (VPP, IPP) in subjects with normal blood pressure to mild hypertension. J Sano K Ohki T Higuchi K Aihara O Kajimoto S Nakagawa Y Kajimoto Y Nakamura, J Nutr Food 2005 7 17 30
35. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. MR Law NJ Wald JK Morris RE Jordan, BMJ 2003 326 1427 1431 10.1136/bmj.326.7404.1427 12829555
36. Renin-angiotensin system and cardiovascular risk. RE Schmieder KF Hilgers MP Schlaich BM Schmidt, Lancet 2007 369 1208 1219 10.1016/S0140-6736(07)60242-6 17416265
37. ACE inhibitors, angiotensin receptor antagonists and bradykinin. M Schachter, J Renin Angiotensin Aldosterone Syst 2000 1 27 29 10.3317/jraas.2000.005 11967793
38. Lactotripeptides and antihypertensive effects: a critical review. E Boelsma J Kloek, Br J NUtr 2009 101 776 786 10.1017/S0007114508137722 19061526
39. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. K Aihara O Kajimoto H Hirata R Takahashi Y Nakamura, J Am Coll Nutr 2005 24 257 265 16093403
40. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. J He PK Whelton LJ Appel J Charleston MJ Klag, Hypertension 2000 35 544 549 10679495
41. National High Blood Pressure Education Program Coordinating Committee: Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. PK Whelton J He LJ Appel JA Cutler S Havas TA Kotchen EJ Roccella R Stout C Vallbona,, et al. JAMA 2002 288 1882 1888 10.1001/jama.288.15.1882 12377087
42. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. SP Whelton A Chin X Xin J He, Ann Intern Med 2002 136 493 503 11926784
43. DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. FM Sacks LP Svetkey WM Vollmer LJ Appel GA Bray D Harsha E Obarzanek PR Conlin ER Miller,, et al. N Engl J Med 2001 344 3 10 10.1056/NEJM200101043440101 11136953
44. Effects of alcohol reduction on blood pressure: A meta-analysis of randomized controlled trials. X Xin J He MG Frontini LG Ogden OI Motsamai PK Whelton, Hypertension 2001 38 1112 1117 10.1161/hy1101.093424 11711507
45. Implications of small reductions in diastolic blood pressure for primary prevention. NR Cook J Cohen PR Hebert JO Taylor CH Hennekens, Arch Intern Med 1995 155 701 709 10.1001/archinte.155.7.701 7695458